Facebook
Twitter
LinkedIn

Media Center

FAST, Fellow and CARB-X Update January 2019
Facebook
Twitter
LinkedIn

FAST & Fellows Round-Up

CARB-X Updates

  • Powered by CARB-X company Achaogen announced FDA clearance and launch for the Thermo Scientific QMS Plazomicin Immunoassay Read More
  • Powered by CARB-X company Vedanta Biosciences raises $27M Series C financing to advance its clinical pipeline of microbiome-derived product candidates Read More
  • Powered by CARB-X company Forge Therapeutics is granted a second award of up to $11.1M from CARB-X to support development of their LpxC inhibitor to treat serious lung infections Read More
  • Powered by CARB-X company ContraFect receives an additional $2.3M in funding from CARB-X to support their gram-negative lysin program Read More